BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mabonga L, Kappo AP. Protein-protein interaction modulators: advances, successes and remaining challenges. Biophys Rev 2019;11:559-81. [PMID: 31301019 DOI: 10.1007/s12551-019-00570-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Saldías MP, Maureira D, Orellana-Serradell O, Silva I, Lavanderos B, Cruz P, Torres C, Cáceres M, Cerda O. TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer. Front Oncol 2021;11:621614. [PMID: 34178620 DOI: 10.3389/fonc.2021.621614] [Reference Citation Analysis]
2 Sindhikara D, Wagner M, Gkeka P, Güssregen S, Tiwari G, Hessler G, Yapici E, Li Z, Evers A. Automated Design of Macrocycles for Therapeutic Applications: From Small Molecules to Peptides and Proteins. J Med Chem 2020;63:12100-15. [PMID: 33017535 DOI: 10.1021/acs.jmedchem.0c01500] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Dey A, Kundu M, Das S, Jena BC, Mandal M. Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer. Biochim Biophys Acta Rev Cancer 2022;:188692. [PMID: 35122882 DOI: 10.1016/j.bbcan.2022.188692] [Reference Citation Analysis]
4 Cheng SS, Yang GJ, Wang W, Leung CH, Ma DL. The design and development of covalent protein-protein interaction inhibitors for cancer treatment. J Hematol Oncol 2020;13:26. [PMID: 32228680 DOI: 10.1186/s13045-020-00850-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
5 Emwas AH, Szczepski K, Poulson BG, Chandra K, McKay RT, Dhahri M, Alahmari F, Jaremko L, Lachowicz JI, Jaremko M. NMR as a "Gold Standard" Method in Drug Design and Discovery. Molecules 2020;25:E4597. [PMID: 33050240 DOI: 10.3390/molecules25204597] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
6 Centorrino F, Andlovic B, Cossar P, Brunsveld L, Ottmann C. Fragment-based exploration of the 14-3-3/Amot-p130 interface. Curr Res Struct Biol 2022;4:21-8. [PMID: 35036934 DOI: 10.1016/j.crstbi.2021.12.003] [Reference Citation Analysis]
7 Tang JQ, Veggiani G, Singer A, Teyra J, Chung J, Sidhu SS. A Panel of Engineered Ubiquitin Variants Targeting the Family of Domains Found in Ubiquitin Specific Proteases (DUSPs). J Mol Biol 2021;433:167300. [PMID: 34666042 DOI: 10.1016/j.jmb.2021.167300] [Reference Citation Analysis]
8 Maurer TS, Edwards M, Hepworth D, Verhoest P, Allerton CMN. Designing small molecules for therapeutic success: A contemporary perspective. Drug Discov Today 2021:S1359-6446(21)00424-4. [PMID: 34601124 DOI: 10.1016/j.drudis.2021.09.017] [Reference Citation Analysis]
9 Egaña-Gorroño L, López-Díez R, Yepuri G, Ramirez LS, Reverdatto S, Gugger PF, Shekhtman A, Ramasamy R, Schmidt AM. Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models. Front Cardiovasc Med 2020;7:37. [PMID: 32211423 DOI: 10.3389/fcvm.2020.00037] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]
10 Chow JT, Salmena L. Recent advances in PTEN signalling axes in cancer. Fac Rev 2020;9:31. [PMID: 33659963 DOI: 10.12703/r/9-31] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Alkhashrom S, Kicuntod J, Häge S, Schweininger J, Muller YA, Lischka P, Marschall M, Eichler J. Exploring the Human Cytomegalovirus Core Nuclear Egress Complex as a Novel Antiviral Target: A New Type of Small Molecule Inhibitors. Viruses 2021;13:471. [PMID: 33809234 DOI: 10.3390/v13030471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Dewey JA, Azizi SA, Lu V, Dickinson BC. A System for the Evolution of Protein-Protein Interaction Inducers. ACS Synth Biol 2021. [PMID: 34319091 DOI: 10.1021/acssynbio.1c00276] [Reference Citation Analysis]
13 Helton LG, Rideout HJ, Herberg FW, Kennedy EJ. Leucine rich repeat kinase 2 ( LRRK2 ) peptide modulators: Recent advances and future directions. Peptide Science 2022;114. [DOI: 10.1002/pep2.24251] [Reference Citation Analysis]
14 Wu L, Su L, Deng M, Hong X, Wu M, Zhang M, Bouveret E, Yan X. Dual-fluorescent bacterial two-hybrid system for quantitative Protein-Protein interaction measurement via flow cytometry. Talanta 2021;233:122549. [PMID: 34215052 DOI: 10.1016/j.talanta.2021.122549] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gulotta MR, Vittorio S, Gitto R, Perricone U, De Luca L. Exploring Molecular Contacts of MUC1 at CIN85 Binding Interface to Address Future Drug Design Efforts. Int J Mol Sci 2021;22:2208. [PMID: 33672244 DOI: 10.3390/ijms22042208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kim DK, Song B, Han S, Jang H, Bae SH, Kim HY, Lee SH, Lee S, Kim JK, Kim HS, Hong KM, Lee BI, Youn HD, Kim SY, Kang SW, Jang H. Phosphorylation of OCT4 Serine 236 Inhibits Germ Cell Tumor Growth by Inducing Differentiation. Cancers (Basel) 2020;12:E2601. [PMID: 32932964 DOI: 10.3390/cancers12092601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wang L, Shen Q, Liao H, Fu H, Wang Q, Yu J, Zhang W, Chen C, Dong Y, Yang X, Guo Q, Zhang J, Zhang J, Zhang W, Lin H, Duan Y. Multi-Arm PEG/Peptidomimetic Conjugate Inhibitors of DR6/APP Interaction Block Hematogenous Tumor Cell Extravasation. Adv Sci (Weinh) 2021;8:e2003558. [PMID: 34105277 DOI: 10.1002/advs.202003558] [Reference Citation Analysis]
18 Algar S, Martín-Martínez M, González-Muñiz R. Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators. Eur J Med Chem 2021;211:113015. [PMID: 33423841 DOI: 10.1016/j.ejmech.2020.113015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Giusto E, Yacoubian TA, Greggio E, Civiero L. Pathways to Parkinson's disease: a spotlight on 14-3-3 proteins. NPJ Parkinsons Dis 2021;7:85. [PMID: 34548498 DOI: 10.1038/s41531-021-00230-6] [Reference Citation Analysis]
20 Rouhani M, Hadi-Alijanvand H. Effect of Lithium Drug on Binding Affinities of Glycogen Synthase Kinase-3 β to Its Network Partners: A New Computational Approach. J Chem Inf Model 2021;61:5280-92. [PMID: 34533953 DOI: 10.1021/acs.jcim.1c00952] [Reference Citation Analysis]
21 Choi J, Yun JS, Song H, Kim NH, Kim HS, Yook JI. Exploring the chemical space of protein-protein interaction inhibitors through machine learning. Sci Rep 2021;11:13369. [PMID: 34183730 DOI: 10.1038/s41598-021-92825-5] [Reference Citation Analysis]
22 Metelytsia LO, Trush MM, Kovalishyn VV, Hodyna DM, Kachaeva MV, Brovarets VS, Pilyo SG, Sukhoveev VV, Tsyhankov SA, Blagodatnyi VM, Semenyuta IV. 1,3-Oxazole derivatives of cytisine as potential inhibitors of glutathione reductase of Candida spp.: QSAR modeling, docking analysis and experimental study of new anti-Candida agents. Computational Biology and Chemistry 2021;90:107407. [DOI: 10.1016/j.compbiolchem.2020.107407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lee J, Worrall LJ, Vuckovic M, Rosell FI, Gentile F, Ton AT, Caveney NA, Ban F, Cherkasov A, Paetzel M, Strynadka NCJ. Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site. Nat Commun 2020;11:5877. [PMID: 33208735 DOI: 10.1038/s41467-020-19662-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 16.5] [Reference Citation Analysis]
24 Basu R, Nahar K, Kulkarni P, Kerekes O, Sattler M, Hall Z, Neggers S, Holub JM, Kopchick JJ. A novel peptide antagonist of the human growth hormone receptor. J Biol Chem 2021;296:100588. [PMID: 33774052 DOI: 10.1016/j.jbc.2021.100588] [Reference Citation Analysis]
25 Shirey RJ, Hart JR, Sridharan B, Novick SJ, Turner LD, Zhou B, Nielsen AL, Eubanks LM, Ueno L, Hixon MS, Lairson LL, Spicer TP, Scampavia LD, Griffin PR, Vogt PK, Janda KD. Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay. Bioorg Med Chem 2021;42:116246. [PMID: 34130216 DOI: 10.1016/j.bmc.2021.116246] [Reference Citation Analysis]
26 Johnston DS, Goldberg E. Preclinical contraceptive development for men and women. Biol Reprod 2020;103:147-56. [PMID: 32561907 DOI: 10.1093/biolre/ioaa076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
27 Wu H, Yao H, He C, Jia Y, Zhu Z, Xu S, Li D, Xu J. Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.03.019] [Reference Citation Analysis]
28 Singh N, Chaput L, Villoutreix BO. Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces. J Chem Inf Model 2020;60:3910-34. [PMID: 32786511 DOI: 10.1021/acs.jcim.0c00545] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Shi L, Zhang N. Applications of Solution NMR in Drug Discovery. Molecules 2021;26:576. [PMID: 33499337 DOI: 10.3390/molecules26030576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Kosugi T, Ohue M. Quantitative Estimate Index for Early-Stage Screening of Compounds Targeting Protein-Protein Interactions. Int J Mol Sci 2021;22:10925. [PMID: 34681589 DOI: 10.3390/ijms222010925] [Reference Citation Analysis]
31 Vittorio S, Seidel T, Garon A, Gitto R, Langer T, De Luca L. In Silico Identification of Potential Druggable Binding Sites on CIN85 SH3 Domain. Int J Mol Sci 2021;22:E534. [PMID: 33430321 DOI: 10.3390/ijms22020534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Krabill AD, Zhang ZY. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases. Biochem Soc Trans 2021;49:1723-34. [PMID: 34431504 DOI: 10.1042/BST20201308] [Reference Citation Analysis]
33 Chang CK, Lin SM, Satange R, Lin SC, Sun SC, Wu HY, Kehn-Hall K, Hou MH. Targeting protein-protein interaction interfaces in COVID-19 drug discovery. Comput Struct Biotechnol J 2021;19:2246-55. [PMID: 33936565 DOI: 10.1016/j.csbj.2021.04.003] [Reference Citation Analysis]
34 Farooq QUA, Shaukat Z, Aiman S, Li CH. Protein-protein interactions: Methods, databases, and applications in virus-host study. World J Virol 2021; 10(6): 288-300 [PMID: 34909403 DOI: 10.5501/wjv.v10.i6.288] [Reference Citation Analysis]
35 Bauman KD, Butler KS, Moore BS, Chekan JR. Genome mining methods to discover bioactive natural products. Nat Prod Rep 2021;38:2100-29. [PMID: 34734626 DOI: 10.1039/d1np00032b] [Reference Citation Analysis]
36 Lee EJ, Ahmad K, Pathak S, Lee S, Baig MH, Jeong JH, Doh KO, Lee DM, Choi I. Identification of Novel FNIN2 and FNIN3 Fibronectin-Derived Peptides That Promote Cell Adhesion, Proliferation and Differentiation in Primary Cells and Stem Cells. Int J Mol Sci 2021;22:3042. [PMID: 33809794 DOI: 10.3390/ijms22063042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, Yang W, Tian C, Miao Z, Wang T, Yang S. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Ther 2021;6:201. [PMID: 34054126 DOI: 10.1038/s41392-021-00572-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Shin WH, Kumazawa K, Imai K, Hirokawa T, Kihara D. Current Challenges and Opportunities in Designing Protein-Protein Interaction Targeted Drugs. Adv Appl Bioinform Chem 2020;13:11-25. [PMID: 33209039 DOI: 10.2147/AABC.S235542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
39 McPherson KS, Korzhnev DM. Targeting protein-protein interactions in the DNA damage response pathways for cancer chemotherapy. RSC Chem Biol 2021;2:1167-95. [PMID: 34458830 DOI: 10.1039/d1cb00101a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Trisciuzzi D, Siragusa L, Baroni M, Autiero I, Nicolotti O, Cruciani G. Getting Insights into Structural and Energetic Properties of Reciprocal Peptide-Protein Interactions. J Chem Inf Model 2022. [PMID: 35148095 DOI: 10.1021/acs.jcim.1c01343] [Reference Citation Analysis]
41 Conlon IL, Drennen B, Lanning ME, Hughes S, Rothhaas R, Wilder PT, MacKerell AD Jr, Fletcher S. Rationally Designed Polypharmacology: α-Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl-1 and HDM2. ChemMedChem 2020;15:1691-8. [PMID: 32583936 DOI: 10.1002/cmdc.202000278] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Kirchhofer D, Burdick DJ, Skelton NJ, Zhang Y, Ultsch M. Regions of conformational flexibility in the proprotein convertase PCSK9 and design of antagonists for LDL cholesterol lowering. Biochemical Society Transactions 2020;48:1323-36. [DOI: 10.1042/bst20190672] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Hall D. Biophysical Reviews: promoting the African synchrotron facility, partnering with national biophysical societies, highlighting advances in structural biology. Biophys Rev 2019;11:495-7. [PMID: 31338694 DOI: 10.1007/s12551-019-00577-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Park T, Woo H, Yang J, Kwon S, Won J, Seok C. Protein oligomer structure prediction using GALAXY in CASP14. Proteins 2021. [PMID: 34363243 DOI: 10.1002/prot.26203] [Reference Citation Analysis]
45 Zhao XZ, Liu F, Burke TR Jr. Application of Post Solid-Phase Oxime Ligation to Fine-Tune Peptide-Protein Interactions. Molecules 2020;25:E2807. [PMID: 32570752 DOI: 10.3390/molecules25122807] [Reference Citation Analysis]
46 De Simone A, Tumiatti V, Andrisano V, Milelli A. Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer's Disease Multitarget Drug Discovery? J Med Chem 2021;64:26-41. [PMID: 33346659 DOI: 10.1021/acs.jmedchem.0c00931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Hall D. 2019-A year in Biophysical Reviews. Biophys Rev 2019;11:833-9. [PMID: 31741173 DOI: 10.1007/s12551-019-00607-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Eberle SA, Gustavsson M. A Scintillation Proximity Assay for Real-Time Kinetic Analysis of Chemokine–Chemokine Receptor Interactions. Cells 2022;11:1317. [DOI: 10.3390/cells11081317] [Reference Citation Analysis]
49 Veale CGL. Into the Fray! A Beginner's Guide to Medicinal Chemistry. ChemMedChem 2021;16:1199-225. [PMID: 33591595 DOI: 10.1002/cmdc.202000929] [Reference Citation Analysis]
50 Sánchez-pardo S, Ochoa-díaz A, Prieto-ortiz JE. Alteraciones Hepaticas en pacientes con infección por VIH en un centro de investigacion en Bogotá Colombia 2009 – 2019. Infect 2021;25:250. [DOI: 10.22354/in.v25i4.956] [Reference Citation Analysis]
51 Dike PP, Bhowmick S, Eldesoky GE, Wabaidur SM, Patil PC, Islam MA. In silico identification of small molecule modulators for disruption of Hsp90-Cdc37 protein-protein interaction interface for cancer therapeutic application. J Biomol Struct Dyn 2020;:1-17. [PMID: 33095103 DOI: 10.1080/07391102.2020.1835714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Howell LA, Beekman AM. In silico peptide-directed ligand design complements experimental peptide-directed binding for protein-protein interaction modulator discovery. RSC Chem Biol 2021;2:215-9. [PMID: 34458784 DOI: 10.1039/d0cb00148a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Ballone A, Picarazzi F, Prosser C, Davis J, Ottmann C, Mori M. Experimental and Computational Druggability Exploration of the 14-3-3ζ/SOS1pS1161 PPI Interface. J Chem Inf Model 2020;60:6555-65. [PMID: 33138374 DOI: 10.1021/acs.jcim.0c00722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Rosell M, Fernández-Recio J. Docking-based identification of small-molecule binding sites at protein-protein interfaces. Comput Struct Biotechnol J 2020;18:3750-61. [PMID: 33250973 DOI: 10.1016/j.csbj.2020.11.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Yang X, Amgad M, Cooper LAD, Du Y, Fu H, Ivanov AA. High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients. J Transl Med 2020;18:334. [PMID: 32873298 DOI: 10.1186/s12967-020-02502-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Nebl S, Alwan WS, Williams ML, Sharma G, Taylor A, Doak BC, Wilde KL, Mcmahon RM, Halili MA, Martin JL, Capuano B, Fenwick RB, Mohanty B, Scanlon MJ. NMR fragment screening reveals a novel small molecule binding site near the catalytic surface of the disulfide–dithiol oxidoreductase enzyme DsbA from Burkholderia pseudomallei. J Biomol NMR 2020;74:595-611. [DOI: 10.1007/s10858-020-00339-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Elwakeel A. Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far. Front Cell Dev Biol 2022;10:879632. [DOI: 10.3389/fcell.2022.879632] [Reference Citation Analysis]
58 Sippl W, Ntie-Kang F. Editorial to Special Issue-"Structure-Activity Relationships (SAR) of Natural Products". Molecules 2021;26:E250. [PMID: 33418945 DOI: 10.3390/molecules26020250] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Hwang HJ, Kim JS, Lee J, Min JS, Jeong KB, Kim E, Lee MK, Chi SW. Single-Molecule Sensing of an Anticancer Therapeutic Protein-Protein Interaction Using the Chemically Modified OmpG Nanopore. Anal Chem 2022. [PMID: 35583342 DOI: 10.1021/acs.analchem.1c04840] [Reference Citation Analysis]
60 Bhat EA, Sajjad N, Banawas S, Khan J. Human CALHM5: Insight in large pore lipid gating ATP channel and associated neurological pathologies. Mol Cell Biochem 2021;476:3711-8. [PMID: 34089472 DOI: 10.1007/s11010-021-04198-y] [Reference Citation Analysis]
61 Ueda T, Tamura T, Kawano M, Shiono K, Hobor F, Wilson AJ, Hamachi I. Enhanced Suppression of a Protein–Protein Interaction in Cells Using Small-Molecule Covalent Inhibitors Based on an N -Acyl- N -alkyl Sulfonamide Warhead. J Am Chem Soc 2021;143:4766-74. [DOI: 10.1021/jacs.1c00703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
62 Marchand A, Van Hall-beauvais AK, Correia BE. Computational design of novel protein–protein interactions – An overview on methodological approaches and applications. Current Opinion in Structural Biology 2022;74:102370. [DOI: 10.1016/j.sbi.2022.102370] [Reference Citation Analysis]
63 Modell AE, Marrone F 3rd, Panigrahi NR, Zhang Y, Arora PS. Peptide Tethering: Pocket-Directed Fragment Screening for Peptidomimetic Inhibitor Discovery. J Am Chem Soc 2022. [PMID: 35029987 DOI: 10.1021/jacs.1c09666] [Reference Citation Analysis]
64 Das SK, Maji S, Wechman SL, Bhoopathi P, Pradhan AK, Talukdar S, Sarkar D, Landry J, Guo C, Wang XY, Cavenee WK, Emdad L, Fisher PB. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis. Pharmacol Res 2020;155:104695. [PMID: 32061839 DOI: 10.1016/j.phrs.2020.104695] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
65 Wang Z, Huang W, Zhou K, Ren X, Ding K. Targeting the Non-Catalytic Functions: a New Paradigm for Kinase Drug Discovery? J Med Chem 2022. [PMID: 35000385 DOI: 10.1021/acs.jmedchem.1c01978] [Reference Citation Analysis]
66 Gupta P, Mohanty D. SMMPPI: a machine learning-based approach for prediction of modulators of protein-protein interactions and its application for identification of novel inhibitors for RBD:hACE2 interactions in SARS-CoV-2. Brief Bioinform 2021:bbab111. [PMID: 33839740 DOI: 10.1093/bib/bbab111] [Reference Citation Analysis]